These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2154814)

  • 1. Enhanced affinity of mu-opioid receptors in morphine-dependent mice.
    Abdelhamid EE; Takemori AE
    Prog Clin Biol Res; 1990; 328():523-6. PubMed ID: 2154814
    [No Abstract]   [Full Text] [Related]  

  • 2. The direct demonstration of binding of mu, delta and kappa agonists to digitonin-solubilized opioid receptors from bovine striatum.
    Crema G; Gioannini TL; Hiller JM; Simon EJ
    NIDA Res Monogr; 1986; 75():9-12. PubMed ID: 2829015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of 125I-beta-endorphin to rat striatal mu- and delta-opioid receptors under physiological conditions: evidence for an opioid receptor complex.
    Schoffelmeer AN; Yao YH; Simon EJ
    Prog Clin Biol Res; 1990; 328():105-8. PubMed ID: 2154760
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced affinity of opiate receptors for naloxone in striatal slices of morphine-dependent mice.
    Kitano T; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):341-51. PubMed ID: 199923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P modulation of [3H]DAGO binding in the brain of Swiss-Webster and CXBK (mu opioid receptor deficient) mice.
    Krumins SA; Kim DC; Larson AA
    Prog Clin Biol Res; 1990; 328():149-52. PubMed ID: 1689493
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the enhanced affinity of opioid receptors for naloxone in morphine-dependent mice.
    Kitano T; Takemori AE
    J Pharmacol Exp Ther; 1979 Jun; 209(3):456-61. PubMed ID: 220409
    [No Abstract]   [Full Text] [Related]  

  • 8. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
    Sánchez-Blázquez P; García-Espãna A; Garzón J
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
    Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
    Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine-6-glucuronide and morphine: mu-opioid receptor binding and effects on dopamine-sensitive adenylate cyclase in striatum.
    Christensen CB; Mørk A; Geisler A
    Pharmacol Toxicol; 1991 Nov; 69(5):396-8. PubMed ID: 1666432
    [No Abstract]   [Full Text] [Related]  

  • 14. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H] beta-funaltrexamine ([3H] beta-FNA) binds irreversibly to mu opioid receptors in the rat brain: autoradiographic study.
    Liu-Chen LY; Li SX; Rohrbach KW; Lewis ME
    Prog Clin Biol Res; 1990; 328():61-4. PubMed ID: 2154819
    [No Abstract]   [Full Text] [Related]  

  • 17. Mu/delta opioid site selectivity of some antidepressants.
    Codd EE; Walker RF
    NIDA Res Monogr; 1986; 75():351-4. PubMed ID: 2828984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA; Houghten R; Pasternak GW
    Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.